Swedbank AB Has $59.02 Million Stock Holdings in HealthEquity, Inc. $HQY

Swedbank AB raised its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 61.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 706,300 shares of the company’s stock after buying an additional 269,000 shares during the quarter. Swedbank AB’s holdings in HealthEquity were worth $59,025,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Wasatch Advisors LP boosted its position in shares of HealthEquity by 9.3% in the first quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock valued at $601,949,000 after acquiring an additional 613,288 shares during the period. Geode Capital Management LLC increased its position in HealthEquity by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock worth $201,685,000 after acquiring an additional 5,671 shares during the period. Westfield Capital Management Co. LP boosted its holdings in HealthEquity by 13.7% in the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after purchasing an additional 235,794 shares during the period. William Blair Investment Management LLC acquired a new stake in HealthEquity in the 4th quarter worth $169,956,000. Finally, AQR Capital Management LLC grew its position in HealthEquity by 59.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock worth $167,200,000 after purchasing an additional 656,820 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Price Performance

HealthEquity stock opened at $96.98 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The company has a market capitalization of $8.11 billion, a PE ratio of 36.32, a price-to-earnings-growth ratio of 1.62 and a beta of 0.21. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $105.96. The business has a 50 day simple moving average of $86.70 and a 200 day simple moving average of $84.61.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares of the company’s stock, valued at $1,775,970. The trade was a 11.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 15,551 shares of company stock worth $1,427,650 in the last quarter. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on HQY. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Wall Street Zen cut HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday. Citizens Jmp raised their price objective on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Finally, Wells Fargo & Company set a $111.00 target price on HealthEquity in a research report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $110.57.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.